Dihexa 10 mg, 30 caps
US$ 29.45
ghk-cu topically ENHANCED EXTENDS PEPTIDE PLATFORM WITH TOPICAL GHK-CU, FORMULATED UNDER MEDICAL COMMISSION OVERSIGHT no silicones GHK-Cu Scalp Solution | Empower
Description
Recommended dosing of 1-2 mg subcutaneous injection 2-3x per week (6 mg/week total) compares to toxic dose estimated at ~22,500 mg (approximately 3,750 times higher than weekly dose)
Certain surgical procedures of the digestive system
PMID 35005595
In preclinical research, TB-500 has been studied for promotion of endothelial and keratinocyte migration, cardiac tissue repair models, anti-inflammatory effects in muscle and connective tissue models, and systemic distribution to multiple tissue types
